Huron Consulting Group 2026 Q2 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- Huron Consulting Group reported record revenues before reimbursable expenses (RBR) of $465.6 million in Q2 2026, up 15.7% from $402.5 million in Q2 2025, driven by 10.8% organic growth across healthcare, education, and commercial segments.
- Net income was $31.2 million or $1.91 per diluted share in Q2 2026, compared to $19.4 million or $1.09 per diluted share in Q2 2025, with net income as a percentage of total revenues increasing to 6.6% from 4.7%.
- Adjusted EBITDA was $72.6 million or 15.6% of RBR in Q2 2026, compared to $60.6 million or 15.1% of RBR in Q2 2025, reflecting margin expansion.
- Healthcare segment RBR grew 17.4% to $232.3 million, including $10.1 million from acquisitions, with operating income margin stable at 30.1%.
- Education segment RBR increased 7.8% to $139.4 million, driven by digital and managed services, with operating margin improving to 26.8% from 25%.
- Commercial segment RBR grew 24.6% to $94 million, including $9.2 million from acquisitions, with operating margin rising to 21% from 16.6%.
- Cash flow from operations was $120.5 million in Q2 2026, up from $80.1 million in Q2 2025, with free cash flow of $111.3 million after $9.1 million in capital expenditures.
- The company repurchased $53.1 million of shares in Q2 2026, totaling $208.6 million year to date, representing 9% of outstanding shares at the start of the year.
- Leverage ratio improved to 2.8 times adjusted EBITDA as of June 30, 2026, down from 3.1 times at March 31, 2026, with a target of 2 to 2.5 times by year-end.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Good afternoon, and welcome to Huron Consulting Group's webcast to discuss financial results for the second quarter of 2026. At this time, all conference call lines are in a listen-only mode. Later, we will conduct a question and answer session for conference call participants, and instructions will follow at that time. As a reminder, this conference call is being recorded. Before we begin, I would like to point all of you to the disclosure at the end of the company's news release for information about any forward-looking statements that may be made or discussed on this call. The news release is posted on Huron's website. Please review that information along with the filings with the SEC for a disclosure of factors that may impact subjects discussed in this afternoon's webcast. The company will be discussing one or more non-GAAP financial measures.
Please look at the earnings release and on Huron's website for all of the disclosures required by the SEC, including reconciliation to the most comparable GAAP numbers. Now, I would like to turn the call over to Mark Hussey, Chief Executive Officer and President of Huron Consulting Group. Mr. Hussey, please go ahead.
Good afternoon, and welcome to Huron Consulting Group's second quarter 2026 earnings call. With me today are John Kelly, our Chief Financial Officer, and Ronnie Dale, our Chief Operating Officer. Led by strong organic growth across all three operating segments, we achieved record revenues before reimbursable expenses or RBR in the second quarter of 2026, increasing 16% compared to the second quarter of 2025. That included record RBR across both our consulting, advanced services, and our digital capabilities. We're pleased with this meaningful step-up in our RBR growth trajectory, our continued margin expansion, plus cash flow from operations delivered in the quarter. In addition, client bookings were up across all three segments during the first half of the year, with an acceleration during the second quarter.
Our strong first half performance, coupled with the continued strength of our backlog and pipeline, reinforce our confidence in increasing our full-year RBR and earnings guidance, building upon our strong track record of consistent growth and margin expansion since 2021. Before I turn to our second quarter performance, let me provide some additional insights on how AI is creating growth opportunities and adding value to our business. Increasingly, organizations are turning to Huron to understand how the rapidly evolving AI and technology landscape can drive growth and operational improvement. Our teams are focused on helping clients address critical business priorities while executing shoulder to shoulder with them to integrate technology, including frontier AI models, and to redesign workflows and operating processes to help drive and sustain tangible outcomes and improve financial returns. AI is driving demand for our digital services.
During the first half of 2026, total bookings for our digital capability increased by more than 20% compared to the same period a year ago, and greater than 60% of those bookings have either direct AI scope for our clients or will have delivery that is significantly enabled by our AI tools. This is a significant increase in mix, as such projects represented approximately 35% of our total bookings in the first half of 2025. We are increasingly confident that AI represents a significant revenue growth opportunity for our digital capability. We continue to embed our deep industry expertise and proprietary data and insights into our AI-enabled solutions, strengthening the differentiation of our offerings and enhancing tangible outcomes delivered to our clients.
One good example of how AI is driving value in our healthcare business is our clinical intelligent automation solution, which gives healthcare organizations a scalable way to combine their trusted data with Huron's proprietary data and expertise to drive clearer decisions and stronger financial performance. Specifically, this AI-enabled tool captures our proprietary data and insights, analytic methods, consulting playbooks, and it compresses the time to deliver insightful recommendations for clinical-related performance improvement opportunities to just hours rather than days or weeks. As a result, we are able to identify even greater financial benefits even faster for our clients, creating new and expanded opportunities for our implementation services and increasing both our revenue and margin opportunities.
AI continues to expand our addressable market as we offer new, innovative AI services and solutions to our clients, both our own proprietary solutions, as well as those we deliver with our technology partners, such as Anthropic, Microsoft, and AWS. Those engagements range from AI strategy, governance, and data monetization to AI pilots, scaling implementation, and managed services via point solutions and end-to-end transformation. Our views on AI and its potential impact on Huron remain bullish, as we believe AI will prove to be a significant contributor to our future growth. We are confident that our collective strategic, financial, operational, and digital offerings, all enabled by AI, will continue to yield positive revenue growth and margin expansion, as evidenced by our continued strong backlog and pipeline. Now, I will share some additional insight into our second quarter performance.
In the healthcare segment, second quarter RBR grew 17% over the prior year quarter reflecting strong demand for our healthcare managed services, performance improvement, strategy, financial advisory, and digital offerings, as well as incremental RBR from our acquisitions. Excluding the impact of the acquisitions, organic growth for the healthcare segment was 12% in Q2 2026 compared to Q2 2025. A significant portion of the healthcare provider market continues to be financially challenged, which in turn leads to continued growth tailwinds for our business. The One Big Beautiful Bill Act is estimated to reduce federal healthcare spending by over $1 trillion over the next 10 years. The more meaningful regulations are only beginning to take effect for hospitals and health systems.
As these new regulations take effect, we expect strong demand for our portfolio of offerings to continue, as many organizations assess the likely financial and operational impacts on their businesses into 2027 and beyond. In combination with the ongoing trends of labor, supplies, and pharmaceutical costs that are rising faster than reimbursements, we believe the operating environment for the healthcare industry will yield solid demand from our performance improvement, strategy, digital, financial advisory, and managed services offerings, which we expect will continue to provide significant growth opportunities in years ahead. In addition to strength in our consulting offerings, we've also seen strong growth in our healthcare managed services capability, which grew 64% in Q2 2026 compared to Q2 2025, led by 43% organic growth.
Clients are increasingly turning to Huron for managed services because of our differentiated expertise, our consistent delivery of financial benefit, and our continued investments in AI and automation. Managed services business is built upon delivering increased net revenue to our clients, higher cash flow yield, greater patient throughput, and improved patient collections. Like the majority of our performance improvement offerings, our pricing arrangements for managed services are designed around outcome-based models. Proven results are driving both strength and demand for our services, exceptional client retention, and recurring revenue for Huron, as well as higher margins than traditional managed services models. To further enhance our managed services offerings, in the second quarter, we acquired RelateCare, a leading provider of AI-enabled clinical and patient access managed services solutions.
Together, we strengthen our services around the patient journey by improving access and throughput, elevating patient and clinician experiences, and delivering measurable operational and financial performance. As healthcare organizations navigate an increasingly complex regulatory and operating environment, we believe our deep client relationships, differentiated expertise, comprehensive portfolio, and outcomes-driven model position us to sustain strong performance in the healthcare segment. Turning next to the education segment. In the second quarter of 2026, we saw an acceleration of our growth rate as the education segment RBR grew 8% compared to the second quarter of 2025, driven by strong demand for our digital and managed services offerings. Universities and colleges continue to face significant market pressures stemming from multiple factors, including declining enrollments, reduced research revenue, pressure on net tuition, increasing operating costs, and a challenging regulatory environment. These pressures create demand for our differentiated set of offerings.
Given the opportunities and challenges facing the higher education industry, university leaders are moving beyond incremental solutions, pursuing broader enterprise transformation initiatives that modernize operating models, improve student outcomes, and leverage technology, data, analytics, and AI to drive better decisions and greater efficiency. Market disruption facing higher education is creating continued opportunities for our education segment to continually enhance our comprehensive portfolio of strategy, operations, technology, and research offerings to help institutions navigate these challenges and advance their missions. For example, we're further differentiating our offerings through innovative solutions such as AI-enabled research administration tools, which is designed to enhance compliance and improve post-award quality control and reduce administrative backlogs.
Huron's well-established reputation, long history of proven results, and deep client relationships makes us one of the most trusted advisors to the industry, which we believe will drive future growth in this business as we address the comprehensive needs of our higher education clients. In the commercial segment, second quarter RBR grew 25% over the prior quarter, reflecting incremental RBR from our acquisitions, as well as strong demand for our financial advisory and strategy offerings. Excluding the impact of acquisitions, RBR from Q2 2026 grew 12% organically over the second quarter of 2025. The increasing level of complexity in the operating environment for commercial organizations is driving global demand for transformational solutions that can bridge strategy, performance improvement, and technology execution.
We continue to invest organically and through targeted acquisitions to expand our capabilities and deepen our expertise in our core industries within commercial, creating a platform that represented 21% of our total business RBR in the first half of 2026. Our balanced portfolio of offerings, which are relevant in both cyclical and counter-cyclical demand cycles, has improved the durability of growth while expanding our addressable market as we add new capabilities in this segment. We believe the combination of our industry expertise and our capabilities all going to market together in an integrated operating model creates a differentiated value proposition for our clients that will help drive continued growth, diversification, and long-term value creation for our shareholders. Today, I also want to highlight our digital capability.
In the second quarter of 2026, digital capability RBR grew 9% over the prior year quarter and sequentially compared to the first quarter of this year. We strategically invested in our digital business since 2013, combining our deep industry expertise, our operational transformation capabilities, and technology execution to help clients accelerate speed to value and improve the financial return on their technology investments. We've seen the benefits of these investments build over time, including in the second quarter when we achieved record RBR. Our digital business in the healthcare segment achieved strong double-digit percentage growth in the second quarter as clients increased their investments in modernized digital platforms and data foundations as well as distinct AI and automation projects. Based on our backlog and pipeline, we expect to see continued double-digit growth in healthcare in the back half of the year.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
8 people spoke on this call — only 1 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
